(DNLI) Denali Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Denali Therapeutics | (DNLI) share price targets
Complete technical analysis of Denali Therapeutics (DNLI) by charts plus indicators, forecast predictions and share price targets for Denali Therapeutics (DNLI)
Denali Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-11 View latest technical analysis
10 day averaged volume of Denali Therapeutics is 613270
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Fri Oct 2024 | 28.00 | 25.59 | 28.07 | 25.59 | 1.44 times |
| 10 Thu Oct 2024 | 25.74 | 26.00 | 26.02 | 25.28 | 1.568 times |
| 09 Wed Oct 2024 | 26.52 | 26.82 | 27.03 | 26.35 | 0.669 times |
| 08 Tue Oct 2024 | 26.73 | 26.68 | 27.47 | 26.30 | 0.909 times |
| 07 Mon Oct 2024 | 26.60 | 27.89 | 27.89 | 26.22 | 1.563 times |
| 04 Fri Oct 2024 | 28.63 | 28.51 | 28.97 | 28.38 | 0.588 times |
| 03 Thu Oct 2024 | 28.22 | 28.69 | 28.88 | 28.12 | 0.835 times |
| 02 Wed Oct 2024 | 29.03 | 28.37 | 29.07 | 28.02 | 0.883 times |
| 01 Tue Oct 2024 | 28.67 | 29.18 | 29.67 | 28.46 | 1.284 times |
| 30 Mon Sep 2024 | 29.13 | 29.12 | 29.32 | 28.50 | 1.065 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 27.4 as stoploss in an intra day buy trade for a target of 28.96. However, stock will show a bearish move below 27.4.
Share price targets for Denali Therapeutics (DNLI)
| Target Type | Value |
| Downside Target | 18.81 |
| Downside Target | 19.74 |
| Downside Target | 20.43 |
| Downside Target | 23.87 |
| Downside Target | 24.85 |
| Downside Target | 25.90 |
| Upside Target | 28.02 |
| Upside Target | 28.83 |
| Upside Target | 29.67 |
| Upside Target | 30.12 |
| Upside Target | 31.00 |
| Upside Target | 31.28 |
| Upside Target | 32.13 |
Intraday share price targets for Denali Therapeutics (DNLI)
| Target Type | Value |
| Downside Intraday Target | 26.16 |
| Downside Intraday Target | 24.33 |
| Upside Intraday Target | 28.95 |
| Upside Intraday Target | 29.91 |
| Downside Intraday Target | 27.12 |
Weekly technical analysis of Denali Therapeutics (DNLI)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Fri Oct 2024 | 28.00 | 27.89 | 28.07 | 25.28 | 1.321 times |
| 04 Fri Oct 2024 | 28.63 | 29.12 | 29.67 | 28.02 | 0.636 times |
| 27 Fri Sep 2024 | 29.43 | 31.23 | 31.28 | 28.83 | 0.677 times |
| 20 Fri Sep 2024 | 30.91 | 30.77 | 32.13 | 30.12 | 1.005 times |
| 13 Fri Sep 2024 | 30.77 | 25.27 | 31.00 | 24.85 | 1.861 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Denali Therapeutics (DNLI)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Fri Oct 2024 | 28.00 | 29.18 | 29.67 | 25.28 | 0.272 times |
| 30 Mon Sep 2024 | 29.13 | 24.36 | 32.13 | 24.24 | 1.097 times |
| 30 Fri Aug 2024 | 24.44 | 23.80 | 25.90 | 19.74 | 0.881 times |
| 31 Wed Jul 2024 | 24.37 | 23.01 | 25.24 | 20.43 | 0.747 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Denali Therapeutics (DNLI)
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Denali Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Denali Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Denali Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Denali Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 27.6 and Denali Therapeutics (DNLI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Denali Therapeutics (DNLI) stock. Volume based technical analysis of Denali Therapeutics (DNLI) stock is negative.
Denali Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Denali Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Denali Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Denali Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Denali Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 27.6 and Denali Therapeutics (DNLI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Denali Therapeutics (DNLI) stock. Volume based technical analysis of Denali Therapeutics (DNLI) stock is negative.
Denali Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.